Loading clinical trials...
Loading clinical trials...
Mechanisms of Exercise Intolerance in Cystic Fibrosis: Role of PDE5 Inhibition
Conditions
Interventions
Sildenafil 40mg oral capsule
Placebo Oral capsule
Locations
2
United States
National Jewish Health
Denver, Colorado, United States
Augusta University
Augusta, Georgia, United States
Start Date
September 5, 2019
Primary Completion Date
June 30, 2024
Completion Date
June 30, 2024
Last Updated
September 19, 2024
NCT02417740
NCT06616857
NCT07108153
NCT02740868
NCT07303621
NCT07274631
Lead Sponsor
National Jewish Health
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions